Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by bilosellhion Jul 12, 2005 10:17pm
428 Views
Post# 9272573

Chief

ChiefI was looking at oncy's chart and it seems to me that it is nearing a near term moment of truth. it has been in a clear downtrend since the high of april 04 - and has bounced off that downtrend line several times without being able to penetrate to the upside (see late Sep/04, again in late Feb/05 and May/05) that downtrend line is now fast approaching the current support of $3.03 and it looks to me like something will have to give in the not too distant future. there is a possibility oncy could be pulled up by the general rally in the biotechs, but it seems to me there is also a distinct possibilty it could go the other way. if that happens, i don't see any support whatsoever until it hits the $2.10 US - $2.15 area. if it breaks to the upside, it looks to me like there would be a fair amount of resistance at $4.00, again at $4.80 and beyond that at $6. without any substantive news i don't see it making any significant move higher through all those resistance levels (i don't expect any sustainable move higher when they finally announce commencement of US ph I trials - they need some meaningful results and not a 6 patient phaseless prostate trial) while the probability of a move higher looks greater than a move lower only because of biotech in general (not due to anything the company has done), if this stock breaks down technically, you will be able to buy it at $2.15 US, imo. with biotech in rally mode, i suspect there are a lot of bios with much better technicals, risk/rewards and that are in later stage trials expecting significant results. any thoughts on my read of the technicals? TIA
Bullboard Posts